Terms: = Brain cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Prognosis
4 results:
1. Mitochondria Transfer from Mesenchymal Stem Cells Confers Chemoresistance to Glioblastoma Stem Cells through Metabolic Rewiring.
Nakhle J; Khattar K; Özkan T; Boughlita A; Abba Moussa D; Darlix A; Lorcy F; Rigau V; Bauchet L; Gerbal-Chaloin S; Daujat-Chavanieu M; Bellvert F; Turchi L; Virolle T; Hugnot JP; Buisine N; Galloni M; Dardalhon V; Rodriguez AM; Vignais ML
Cancer Res Commun; 2023 Jun; 3(6):1041-1056. PubMed ID: 37377608
[TBL] [Abstract] [Full Text] [Related]
2. Rationally designed drug delivery systems for the local treatment of resected glioblastoma.
Bastiancich C; Malfanti A; Préat V; Rahman R
Adv Drug Deliv Rev; 2021 Oct; 177():113951. PubMed ID: 34461201
[TBL] [Abstract] [Full Text] [Related]
3.
Vallejo-Armenta P; Santos-Cuevas C; Soto-Andonaegui J; Villanueva-Pérez RM; González-Díaz JI; García-Pérez FO; Arrellano-Zarate A; Luna-Gutiérrez M; Azorín-Vega E; Ocampo-García B; Ferro-Flores G
Contrast Media Mol Imaging; 2020; 2020():2525037. PubMed ID: 32410920
[TBL] [Abstract] [Full Text] [Related]
4. Malignant glioma progression and nitric oxide.
Lam-Himlin D; Espey MG; Perry G; Smith MA; Castellani RJ
Neurochem Int; 2006 Dec; 49(8):764-8. PubMed ID: 16971023
[TBL] [Abstract] [Full Text] [Related]
